U.S., Nov. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07918352) titled 'Evaluation of an AI-Assisted Tool for CLABSI Surveillance at VA Medical Centers' on Oct. 24.
Brief Summary: Infection prevention and control programs at US hospitals perform surveillance to detect and publicly report hospital-onset central line-associated bloodstream infections (CLABSI) using standards set by CDC's National Healthcare Safety Network (NHSN). Because this process requires time-consuming review of the medical record by dedicated infection preventionists, VA has developed a generative artificial intelligence (AI) tool that applies the NHSN CLABSI standard to clinical data from the medical record. In this quality improvem...